trial
as of 2026-07-01Multicenter, Randomized, Comparative and Prospective Study Evaluating the Impact on the Care Path of an Editorial Program Accompanied by Advance Directives in Psychiatry (DAP) for People Suffering From Schizophrenia, Bipolar I Disorder or Schizoaffective Disorder
NCTId NCT03630822
at a glance
— · Completed
Enrollment 399 (actual)
Sponsored by Assistance Publique Hopitaux De Marseille
Primary completion 2021-05-10
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
399 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2019-01-02
Primary completion
2021-05-10
Eligibility
ALL · 18 Years
Interventions & indications
Sponsors
Assistance Publique Hopitaux De MarseilleLead Sponsor
Investigators
1
Jean-Olivier ARNAUD, DirectorStudy Director
Sites
1 total
Marseille, France
Facts & assertions
4 sourced
Enrollment
399
Phase
NA
Primary Completion Date
2021-05-10
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
indication
investigator